Product Information
RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.1542 per EA under NDC 00904710761. Its NADAC has been published 279 times since Feb 24, 2021.
The Low Outlier badge above means this manufacturer's average price in the Rivastigmine Tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904710761
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204572On Market Since
3/25/2016
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 279 times since Feb 24, 2021, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1542 per EA |
|---|---|
| All-time high | $0.3828 (Dec 15, 2021) |
| All-time low | $0.1380 (Nov 22, 2023) |
| 52-week high | $0.1894 |
| 52-week low | $0.1458 |
| Median price | $0.1908 |
| Average price | $0.2125 |
| Largest weekly change | +49.6% (Oct 19, 2022) |
| Weeks tracked | 279 |
| Tracking since | Feb 24, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 1.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 1.5 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.1542 per EA (NDC 00904710761), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 1.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has declined 57.4%. It has been tracked across 279 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 1.5 MG CAPSULE?
Since Feb 24, 2021, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has ranged from a low of $0.1380 (Nov 22, 2023) to a high of $0.3828 (Dec 15, 2021), with a median of $0.1908 per EA.
Are there cheaper alternatives to RIVASTIGMINE 1.5 MG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 1.5 MG CAPSULE, is $0.1508 per EA — about 2% below RIVASTIGMINE 1.5 MG CAPSULE.
Who manufactures RIVASTIGMINE 1.5 MG CAPSULE?
RIVASTIGMINE 1.5 MG CAPSULE (NDC 00904710761) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification